End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.24 BGN | -1.27% | -1.89% | +9.09% |
Feb. 29 | Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Dec. 20 | Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023 | CI |
Sales 2024 * | 1.99B 1.1B | Sales 2025 * | - | Capitalization | 1.03B 572M |
---|---|---|---|---|---|
Net income 2024 * | 72M 39.82M | Net income 2025 * | - | EV / Sales 2024 * | 0.52 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
13.6
x | P/E ratio 2025 * |
-
| Employees | 4,721 |
Yield 2024 * |
4.81% | Yield 2025 * |
-
| Free-Float | 46.35% |
1 day | -1.27% | ||
1 week | -1.89% | ||
Current month | +1.30% | ||
1 month | +3.31% | ||
3 months | +9.09% | ||
6 months | -5.45% | ||
Current year | +9.09% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Director of Finance/CFO | - | 01-12-31 | |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Bisera Lazarova
BRD | Director/Board Member | - | - |
Director/Board Member | 60 | 99-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 6.24 | -1.27% | 11,903 |
24-03-26 | 6.32 | -0.32% | 9,467 |
24-03-25 | 6.34 | +0.32% | 4,297 |
24-03-22 | 6.32 | -0.32% | 2,108 |
24-03-21 | 6.34 | -0.31% | 6,463 |
End-of-day quote Bulgaria S.E., March 26, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.09% | 572M | |
-19.49% | 18.13B | |
-29.16% | 11.09B | |
-2.90% | 6.79B | |
-0.60% | 5.57B | |
+10.80% | 5.26B | |
+34.14% | 3.93B | |
-9.43% | 3.75B | |
+4.30% | 3.55B | |
-15.38% | 3.32B |